| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 163.363 | 171.760 | 174.287 | 195.496 | 212.674 | 255.504 | 295.552 | 326.311 | 299.717 | 297.670 |
| Total Income - EUR | 171.258 | 177.207 | 174.288 | 195.498 | 212.680 | 255.514 | 295.600 | 326.431 | 299.732 | 297.682 |
| Total Expenses - EUR | 171.630 | 174.420 | 160.595 | 175.441 | 194.096 | 222.497 | 257.248 | 280.016 | 252.024 | 258.248 |
| Gross Profit/Loss - EUR | -372 | 2.788 | 13.693 | 20.057 | 18.584 | 33.017 | 38.353 | 46.414 | 47.708 | 39.434 |
| Net Profit/Loss - EUR | -372 | 2.249 | 11.879 | 18.102 | 16.453 | 31.115 | 35.452 | 43.180 | 44.699 | 32.938 |
| Employees | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 5 | 5 |
Check the financial reports for the company - Genţiana Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 14.918 | 4.801 | 3.437 | 2.169 | 946 | 607 | 451 | 310 | 166 | 24 |
| Current Assets | 51.367 | 44.397 | 48.064 | 66.237 | 61.770 | 102.388 | 98.576 | 106.215 | 115.635 | 96.874 |
| Inventories | 26.286 | 22.239 | 22.314 | 22.457 | 28.854 | 41.258 | 42.186 | 37.673 | 49.889 | 41.148 |
| Receivables | 16.691 | 4.853 | 17.128 | 21.057 | 20.034 | 30.389 | 38.001 | 38.626 | 40.383 | 21.929 |
| Cash | 8.389 | 17.305 | 8.622 | 22.722 | 12.881 | 30.741 | 18.389 | 29.916 | 25.363 | 33.796 |
| Shareholders Funds | -186 | 2.065 | 13.909 | 31.756 | 16.627 | 47.427 | 35.619 | 43.347 | 44.867 | 33.104 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 66.787 | 47.310 | 37.883 | 36.917 | 46.398 | 55.809 | 63.534 | 63.344 | 71.196 | 63.946 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Genţiana Pharma Srl